Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data

    Basic Details
    Date
    Sunday, August 28, 2022
    Type
    Presentation
    Description

    ​​​​​​This poster examines claims and electronic health record based indicators of obesity and tobacco use among sodium-glucose co-transporter-2 inhibitor (SGLT-2i) users in the FDA Sentinel System. It was presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. 

    Presenter(s)

    Casie Horgan, Po-Yin Chang, Meg Her, Rebecca Hawrusik, Alexander Peters, Catherine Corey, David J. Graham, Judith C. Maro and Noelle M. Cocoros